G. Rice

G. Rice, G. Dekaban, S. Poland, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Preparative isoelectric focusing in agarose.

G. Rice, G. Ebers, H. Armstrong, 1980, Journal of immunological methods.

The natural history of multiple sclerosis.

G. Rice, M. Kremenchutzky, R. Deshpande, 2006, Advances in neurology.

Genetic loading in familial migraine with aura

M. Z. Cader, G. Rice, G. Ebers, 2003, Journal of neurology, neurosurgery, and psychiatry.

ABSENCE OF ANTIBODIES TO HTLV-I AND HTLV-III IN SERA OF PATIENTS WITH MS AND CHRONIC MYELOPATHY

D. Paty, G. Rice, G. Ebers, 1986 .

Mollaret's meningitis associated with herpes simplex type 2 infection

G. Rice, G. Dekaban, F. Picard, 1993, Neurology.

Role of the monocyte in cytomegalovirus-mediated immunosuppression in vitro.

G. Rice, K. Kapasi, 1986, The Journal of infectious diseases.

Mitral Valve Prolapse: a Cause of Stroke in Children?

G. Rice, G. Ebers, R. Bondar, 1981 .

Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses.

S. Cole, J. Selhorst, R. Beck, 2002, Annals of neurology.

Cytomegalovirus in the brain: in vitro infection of human brain-derived cells.

G. Rice, G. Dekaban, P. Costello, 1990, The Journal of infectious diseases.

Tizanidine vs. Baclofen in the Treatment of Spasticity in Patients With Multiple Sclerosis RE: Can. J. Neurol. Sci. 1988; 15:15-19.

G. Rice, 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome.

J. Baskerville, B. Weinshenker, G. Rice, 1991, Brain : a journal of neurology.

The natural history of secondary progressive multiple sclerosis: observations from the London study group.

G. Rice, G. Rice, 2002, Multiple sclerosis.

The natural history of secondary progressive multiple sclerosis: observations from the London study group

G. Rice, 2002 .

Observations from the Natural History Cohort of London, Ontario

J. Baskerville, G. Rice, G. Ebers, 2002 .

Retroviruses and multiple sclerosis. II.

G. Rice, G. Dekaban, 1990, Neurology.

The evolution of neutralizing antibodies in multiple sclerosis patients treated with interferon β-1b

D. Paty, J. Oger, G. Rice, 1999, Neurology.

Natural killer cells activity in patients with multiple sclerosis given α interferon

T. Merigan, G. Rice, P. Casali, 1983 .

A controlled trial of natalizumab for relapsing multiple sclerosis.

David H. Miller, K. Miszkiel, L. Blumhardt, 2003, The New England journal of medicine.

Comparative Analysis of the Antibody Response to the HTLV‐I gag and env Proteins in HTLV‐I Asymptomatic Carriers and HAM/TSP Patients: an Isotype and Subclass Analysis

G. Rice, G. Dekaban, T. Palker, 1994, Scandinavian journal of immunology.

A neurologic rating scale (NRS) for use in multiple sclerosis

R. Knobler, G. Rice, H. Panitch, 1984, Neurology.

Interferon in relapsing-remitting multiple sclerosis.

L. Munari, C. Polman, G. Rice, 2001, The Cochrane database of systematic reviews.

Remission of psoriatic lesions with muromonab-CD3 (orthoclone OKT3) treatment.

B. Weinshenker, G. Rice, B. Bass, 1989, Journal of the American Academy of Dermatology.

Suppression of natural killer cell activity and T cell proliferation by fresh isolates of human cytomegalovirus.

G. Rice, M. Oldstone, R. Schrier, 1986, The Journal of infectious diseases.

Phorbol ester-induced differentiation permits productive human cytomegalovirus infection in a monocytic cell line.

B. Weinshenker, G. Rice, S. Wilton, 1988, Journal of immunology.

Myopathy in Primary Systemic Amyloidosis

W. Brown, G. Rice, D. Boughner, 1988, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Cytomegalovirus-caused release of collagenase IV from human cerebral microvascular endothelial cells.

G. Rice, G. Dekaban, P. Costello, 1995, Clinical and diagnostic virology.

A full genome search in multiple sclerosis

D. Hinds, D. Paty, J. Oger, 1996, Nature Genetics.

Genetic susceptibility to MS: a second stage analysis in Canadian MS families

C. Willer, D. Paty, J. Oger, 2001, Neurogenetics.

Interferons in relapsing remitting multiple sclerosis: a systematic review

L. Munari, C. Polman, G. Rice, 2003, The Lancet.

Bone marrow transplantation in multiple sclerosis

G. Rice, G. Ebers, P. Mandalfino, 2000, Journal of Neurology.

Evidence for a prolonged role of alpha sub 4 integrin throughout active experimental allergic encephalomyelitis

S. Karlik, G. Rice, H. Horner, 1996, Neurology.

Cerebellar astrocytoma with benign histology and malignant clinical course. Case report.

G. Rice, R. Auer, A. Amacher, 1981, Journal of neurosurgery.

PRISMS-4: Long-term efficacy of interferon-&bgr;-1a in relapsing MS

Richard A. C. Hughes, H P Hartung, F Barkhof, 2001, Neurology.

Anti-&agr;4 integrin therapy for multiple sclerosis: Mechanisms and rationale

P. Calabresi, H. Hartung, G. Rice, 2005, Neurology.

Pathological and Molecular Biological Features of a Myelopathy Associated with HTLV-1 Infection

B. Weinshenker, G. Rice, C. Power, 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Encephalopathy in Liver Transplantation: Neuropathology and CMV Infection

G. Rice, C. Power, J. Kaufmann, 1990, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Retroviral Disease of The Nervous System

B. Weinshenker, G. Rice, 1989 .

Significant linkage to migraine with aura on chromosome 11q24.

S. Cherny, G. Rice, G. Ebers, 2003, Human molecular genetics.

Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.

M. Tintoré, G. Rice, J. Palace, 2008, The Cochrane database of systematic reviews.

G. Rice, A. Hudson, 1990, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

A genome-wide scan of male sexual orientation

G. Rice, G. Ebers, L. Handunnetthi, 2010, Journal of Human Genetics.

Virus-induced demyelination in man: models for multiple sclerosis.

G. Rice, 1992, Current opinion in neurology and neurosurgery.

HTLV-1 Associated Myelopathy in Canada

B. Weinshenker, G. Rice, G. Ebers, 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Interferon β-1a in MS

G. Rice, G. Francis, J. Alsop, 2005, Neurology.

Ibuprofen treatment versus gradual introduction of interferon β-1b in patients with MS

R. Knobler, G. Rice, G. Ebers, 1999, Neurology.

Systemic alpha‐interferon therapy of multiple sclerosis

T. Merigan, R. Knobler, G. Rice, 1984, Neurology.

Trichlorethylene Poisoning Mimicking Multiple Sclerosis

G. Rice, J. Noseworthy, 1988, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Spongiform Encephalopathy of Long Duration: A Family Study

D. Paty, A. Kertesz, M. Ball, 1980, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Cytomegalovirus and Rasmussen's encephalitis

J. Girvin, W. Blume, G. Rice, 1990, The Lancet.

Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis

David H. Miller, K. Miszkiel, G. Rice, 2005, Multiple sclerosis.

Recurrent cerebral embolism in cardiac amyloidosis

G. Rice, G. Ebers, G. Wysocki, 1981, Neurology.

HTLV-I infection associated with disease in aboriginal Indians from British Columbia: a serological and PCR analysis.

J. Oger, G. Rice, D. Werker, 1994, Clinical and diagnostic virology.

Cost and health related quality of life consequences of multiple sclerosis

G. Torrance, G. Rice, G. Francis, 2000, Multiple sclerosis.

The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability

George C. Ebers, Martin Daumer, George P. Rice, 2010, Brain : a journal of neurology.

Cladribine and progressive MS

M Filippi, M. Filippi, G. Comi, 2000, Neurology.

The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease.

J. Baskerville, G. Rice, G. Ebers, 2006, Brain : a journal of neurology.

The natural history of multiple sclerosis: a geographically based study. 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis.

J. Baskerville, G. Rice, G. Ebers, 1999, Brain : a journal of neurology.

A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses

R. Scheyer, A. Bar-Or, D. Paty, 2006, Neurology.

Retroviruses and multiple sclerosis. I.

B. Weinshenker, G. Rice, G. Dekaban, 1990, Neurology.

The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials.

J. Baskerville, B. Weinshenker, G. Rice, 1991, Brain : a journal of neurology.

Interferon β‐1a for early multiple sclerosis: CHAMPS trial subgroup analyses

S. Cole, J. Selhorst, R. Beck, 2002 .

Human T-lymphotropic virus type 1 in coastal natives of British Columbia: phylogenetic affinities and possible origins

J. Oger, G. Rice, M. Coulthart, 1995, Journal of virology.

An open‐trial evaluation of mitoxantrone in the treatment of progressive MS

S. Karlik, D. Lee, G. Rice, 1993, Neurology.

Diagnostic brain MRI findings in primary progressive multiple sclerosis

D. Lee, G. Rice, G. Ebers, 2000, Multiple sclerosis.

The extent of human cytomegalovirus replication in primary neurons is dependent on host cell differentiation.

G. Rice, G. Dekaban, L. Bambrick, 1994, The Journal of infectious diseases.

A monoclonal antibody to α4‐integrin reverses the MR‐detectable signs of experimental allergic encephalomyelitis in the Guinea pig

S. Karlik, G. Rice, H. Horner, 1995 .

Immunological complications in multiple sclerosis patients receiving interferon

T. Merigan, R. Knobler, G. Rice, 1985, Annals of neurology.

Clinical Trial of Natural Alpha Interferon in Multiple Sclerosis a

T. Merigan, R. Knobler, G. Rice, 1984, Annals of the New York Academy of Sciences.

The Failure of Monoclonal Antibody‐defined Lymphocyte Subsets to Monitor Disease Activity in Patients with Multiple Sclerosis a

R. Knobler, G. Rice, M. Oldstone, 1984, Annals of the New York Academy of Sciences.

Treatment of Secondary Progressive Multiple Sclerosis

G. Rice, 1999, BioDrugs.

The significance of neutralizing antibodies in patients with multiple sclerosis treated with interferon beta.

G. Rice, 2001, Archives of neurology.

Reduced visual evoked responses in multiple sclerosis patients with optic neuritis: Comparison of functional magnetic resonance imaging and visual evoked potentials

Ravi S. Menon, J. Gati, J. R. Mitchell, 1999, Multiple sclerosis.

Ondansetron, a 5-HT3 antagonist, improves cerebellar tremor.

G. Rice, G. Ebers, G C Ebers, 1997, Journal of neurology, neurosurgery, and psychiatry.

A multicenter, open-label, phase II study of the immunogenicity and safety of a new prefilled syringe (liquid) formulation of Avonex in patients with multiple sclerosis.

D. Arnold, J. Oger, M. Freedman, 2004, Clinical therapeutics.

Disease activity markers in multiple sclerosis Another look at suppressor cells defined by monoclonal antibodies OKT4, OKT5, and OKT8

R. Knobler, G. Rice, M. Oldstone, 1984, Journal of Neuroimmunology.

Baseline MRI characteristics of patients at high risk for multiple sclerosis: results from the CHAMPS trial

Michael Wall, D. Barlett, J. Herbert, 2002, Multiple sclerosis.

Interferons in the treatment of multiple sclerosis: do they prevent the progression of the disease?

G. Rice, G. Ebers, 1998, Archives of neurology.

Randomized study of once-weekly interferon β-1a therapy in relapsing multiple sclerosis: three-year data from the OWIMS study

J. Bouchard, G. Comi, M. Freedman, 2005, Multiple sclerosis.

The effect of cladribine on T1 ‘black hole’ changes in progressive MS

M. Rovaris, M. Filippi, M. Sormani, 2000, Journal of the Neurological Sciences.

Variation in immunoglobulin G and albumin concentrations during lumbar CSF removal

G. Rice, G. Ebers, H. Armstrong, 1982, Neurology.

Predictors of short-term disease activity following a first clinical demyelinating event: analysis of the CHAMPS placebo groupy

Jeffrey A. Cohen, S. Cole, D. Arnold, 2002, Multiple sclerosis.

Treatment with Interferon Beta-1b Improves Quality of Life in Multiple Sclerosis

J. Oger, G. Rice, G. Francis, 1999, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Natalizumab for Relapsing MS

G. Rice, O. Khan, W. Sheremata, 2003 .

Hyperbaric oxygen therapy in chronic stable multiple sclerosis

G. Rice, J. Noseworthy, G. Ebers, 1986, Neurology.

Absence of antibody to HTLV I and III in Sera of Canadian patients with multiple sclerosis and chronic myelopathy

G. Rice, G. Ebers, D. Bulman, 1986, Annals of neurology.

MR imaging field strength: prospective evaluation of the diagnostic accuracy of MR for diagnosis of multiple sclerosis at 0.5 and 1.5 T.

M. Eliasziw, G. Rice, G. Ebers, 1995, Radiology.

Selective spinal cordectomy: clinicopathological correlation.

G. Rice, J. Kaufmann, J. Gilbert, 1982, Journal of neurosurgery.

Interferons in relapsing remitting multiple sclerosis

L. Munari, G. Rice, G. Ebers, 2003, The Lancet.

Nucleotide sequence analysis of an HTLV-I isolate from a Chilean patient with HAM/TSP.

G. Rice, G. Dekaban, D. Waters, 1992, AIDS research and human retroviruses.

Tizanidine Versus Baclofen in the Treatment of Spasticity in Patients with Multiple Sclerosis

B. Weinshenker, G. Rice, B. Bass, 1988, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Male homosexuality: absence of linkage to microsatellite markers at Xq28.

N. Risch, G. Rice, G. Ebers, 1999, Science.

The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.

J. Baskerville, G. Rice, G. Ebers, 1999, Brain : a journal of neurology.

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability.

J. Baskerville, B. Weinshenker, G. Rice, 1989, Brain : a journal of neurology.

The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation.

J. Baskerville, G. Rice, G. Ebers, 1999 .

The Mayo Clinic-Canadian cooperative trial of sulfasalazine in active multiple sclerosis

B. Erickson, D. Lee, G. Rice, 1998, Neurology.

A double‐blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis

B. Weinshenker, G. Rice, B. Bass, 1992, Neurology.

Interferons in relapsing remitting multiple sclerosis: a systematic review

L. Munari, C. Polman, G. Rice, 2003, The Lancet.

The natural history of multiple sclerosis.

G. Rice, M. Kremenchutzky, R. Deshpande, 2006, Advances in neurology.

A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing–remitting multiple sclerosis

G. Rice, G. Ebers, D. Wingerchuk, 2005, Journal of Neurology, Neurosurgery & Psychiatry.